Results 181 to 190 of about 132,779 (360)
Abstract Background The endocannabinoid system is a neuromodulatory system implicated in cellular processes during both development and regeneration. The Mexican axolotl, one of only a few vertebrates capable of central nervous system regeneration, was used to examine the role of the endocannabinoid system in the regeneration of the tail and spinal ...
Michael Tolentino +3 more
wiley +1 more source
Increased α1- and α2-adrenoceptor-mediated contractile responses of human skeletal muscle resistance arteries in chronic limb ischemia [PDF]
Yagna Jarajapu
openalex +1 more source
Abstract Trichorhinophalangeal syndrome (TRPS) is a rare genetic disease inherited in an autosomal dominant manner. It occurs in 1 in 100,000 people globally and is caused by several types of mutations of the TRPS1 gene. Since the first human patient was reported in 1966, typical and atypical pathologies, disease courses, and treatment case ...
Naoya Saeki +6 more
wiley +1 more source
The Management of Acute Limb Ischemia: Techniques for Dealing with Thrombus [PDF]
John R. Laird
openalex +1 more source
Abstract Aims This study aimed to evaluate the change of the main electrocardiographic (ECG) characteristics and their prognostic role across the main subtypes of cardiac amyloidosis [light‐chain amyloidosis (AL) and hereditary (ATTRv) and wild‐type transthyretin amyloidosis (ATTRwt)].
Alessia Argirò +20 more
wiley +1 more source
Impact of empagliflozin in patients with and without T2D or CKD in the EMPACT‐MI trial. Baseline characteristics, HF outcomes and subgroup analysis of efficacy endpoints are shown. # Hazard ratios estimated via Cox proportional hazard model (unless indicated otherwise). ^ Rate ratios via negative binomial regression.
Francesco Fioretti +23 more
wiley +1 more source
Spinal cord stimulation in critical limb ischemia [PDF]
G.H. Spincemaille
openalex +1 more source
PROSTANOIDS IN THE MANAGEMENT OF LIMB ISCHEMIA [PDF]
K M Rai, K K Maudar
openaire +2 more sources

